Trial of Revumenib Plus FLA Chemotherapy for Children With Relapsed or Refractory NUP98-rearranged AML."
Clinical trial NCT07686107 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07686107
- Sponsor
- Therapeutic Advances in Childhood Leukemia Consortium
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-31
- Primary completion
- 2029-12-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.